Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CPB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HTRA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERPINB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZDHHC18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM9B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
AK7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00911 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DMD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC24A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD163 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CFC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANTXR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETFBKMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLGAP1-AS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on